My CV or resume showing my expertise and experience in healthcare, cancer therapy by immunotherapy or radiation by radium 224/Alpha particles and high-technology.

1. Page 1 of 5
Howard David Sterling
www.slideshare.net/search/slideshow?searchfrom=header&q=howard+sterling
https://www.youtube.com/user/SterlingGroupIntl
Strategic thinker, solver &
implementer; Leader &
innovator in pioneering
disruptively innovative
healthcare & high-technologies
in USA, Israel, China & other
countries.
Participated in over 150
NASDAQ IPOs as attorney,
investment banker, founder,
director, and consultant.
Inventor & CEO: Patent Core
concepts of Rama Mail-
completely prevents phishing.
145 West 67 Street, Suite 31D
New York, NY 10023
+1-646-409-5356
+972-52-659-5882
howard.david.sterling@gmail.com

2. Page 2 of 5
www.alphataumedical co-
founder
Pioneer in taking Israeli
healthcare companies to
NASDAQ IPOs since
1981………
Aoxing Pharmaceutical (AXN
NYSE) Director, Chairman of
Audit Committee……………
SonoviaTech.com, (TASE:
SONO)………….
ATM, uniquely using intra-tumoral
DaRTs devices with Ra224 emitting α
particles, most effective solid tumor
therapy with no/small side effects &
consistent abscopal effect.
Latest FOMX (unique topical derm
drugs), raised $160 million; 1981 laser
Industries (first medical laser)
InterPharm Laboratories (among first
genetic engineering companies).
AXN, China-based, producer of Chinese
herbals and leader in bringing opioid
therapeutics to China partnering with
leading opioid Scottish company
Hired to find strategic partners for this
patented-process for impregnating ZnO
nano-particles into textiles, especially
scrubs and hospital linens, thereby killing
all bacteria and viruses which materially
decreases nosocomial, hospital-caused
infections.

3. Page 3 of 5
EXPERIENCE
Rama Mail, Israel — CEO and
Core Inventor
June 2017 - PRESENT
Dreamt of integration of core
concepts of blockchain and
Small Biometric Signature
Alpha Tau Medical, Israel—
Co-Founder and Director
April 2015-present
Uniquely using Ra224
intratumorally, dissolves all
solid tumors in days with no side
effects. Responsible for strategic
large pharmaceutical partners
and strategic financiers
Foamix Pharmaceutical--
Israel--Primary consultant on
$160 million NASDAQ IPO
May 2014-September 2015
Responsible for obtaining major
underwriters and all aspects of
NASDAQ IPO
Various Investment Banks
2010-2014
Sand Bros. Venture Capital
Funds-New York---COO &
head of Investment Banking
SKILLS
 Strategic major financing
 Disruptive Invention
 Pioneer in NASDAQ IPOs for Israeli
companies since 1981
 Software companies to
NASDAQ IPOs since 1965
 Taken 160 companies to NASDAQ as
attorney, consultant or investment
banker
Education
Cornell Agricultural School. 1958-1960.
First in class
Columbia University, 1960-1962, BS,
Economics, Cum Laude, Phi Beta Kappa
Harvard Law School, 1962-1968, Magna
Cum Laude, Harvard Law Review,
Published Paper on “Broker Dealer
Bankruptcy” Harvard Law Review, leading
to SIPC by Congress
“Broker Dealers should be able to Go
Public” UCLA Law Review. Leading to
allowance by NYSE of Members being
publicly traded.
IMAGINE IT IS 1965: As IPO attorney, I
did IPO prospectus’ for PLI compiler &
simulation software companies, new
concepts at time.

4. Page 4 of 5
April 1996-2010
COO of $175 million venture
funds focused on fiber-optic
switches, cabling and quantum
photonics.
Oscar Gruss & Sons-Israel-
Head of Investment Banking.
1991-1996
Pioneer, first USA investment
banker to have office in Israel.
Did 11 NASDAQ IPOs for
Israel companies.
Various Investment Banks
1983-1991
Rifkind & Sterling,
attorneys. Beverly Hills-Senior
Partner
1965-1983
Headed 55 attorneys completely
focused on NASDAQ IPOs,
primarily high-tech electronics
and med-tech. International
reputation.

5. Page 5 of 5
Co-Founder and Grants
Committee Chairman, Concern
Foundation for Cancer Research,
1968-1983, Beverly Hills, CA
SUMMARY: Howard D.
Sterling has been leading IPO
attorney, director, investment
banker consultant, CEO-
inventor, & founder of
innovative medical device,
pharmaceutical & high-tech
companies since 1965 focused
on NASDAQ IPOs. Strategic
thinker, strategic solver;
strategic implementer in USA,
Israel and China latest, AXN,
FOMX and alphatau.com
Concern was first charity focused on
immune-oncology, currently most
fashionable new cancer therapy. Concern
endowed, under my pioneering leadership
and research, Lautenberg Center for General
and Tumor Immunology.